Skip to content

Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.

Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00966953
Enrollment
25
Registered
2009-08-27
Start date
2007-10-31
Completion date
2008-01-31
Last updated
2009-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Diseases

Brief summary

Clinical research study to determine the anti-plaque efficacy of prototype dentifrices via a 4-day brushing regiment

Interventions

DRUGFluoride

Brush twice daily

Brush twice daily

OTHERantibacterial plant extract

Brush twice daily

Sponsors

Colgate Palmolive
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female volunteers 18-65 years of age. * Good general health. * Must sign informed consent form. * Must discontinue oral hygiene on the mornings of each appointment and between sampling periods. * No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.

Exclusion criteria

* Medical condition which requires pre-medication prior to dental procedures/visits. * Medical condition which precludes eating/drinking for 12 hrs. * History of allergy to common dentifrice ingredients. * Subjects unable or unwilling to sign the informed consent form. * Moderate or advanced periodontal disease. * Two or more decayed untreated dental sites at screening. * Other disease of the hard or soft oral tissues. * Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation). * Use of medications that can currently affect salivary flow. * Current use of antibiotics. * Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1. * Pregnant or nursing women. * Participation in any other clinical study within 30 days prior to enrollment into this study. * Use of tobacco products. * Subjects who must receive dental treatment during the study dates. * Current use of Antibiotics for any purpose. * Immune compromised individuals (HIV,AIDS, immuno suppressive drug therapy).

Design outcomes

Primary

MeasureTime frameDescription
Plaque Index8 weeksPlaque score scale: Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Countries

United States

Participant flow

Recruitment details

The dental clinic staff recruited for this study.

Participants by arm

ArmCount
Fluoride Control, Magnolol,Total/Whitening,Honokiol
1st-fluoride only control,2nd-fluoride/magnolol,3rd-triclosan/fluoride control, 4th-fluoride/honokiol
6
Total/Whitening, Honokiol, Fluoride Control, Magnolol
1st-triclosan/fluoride control, 2nd-fluoride/honokiol, 3rd-fluoride only control,4th-fluoride/magnolol
6
Honokiol, Fluoride Control, Magnolol, Total/Whitening
1st-fluoride/honokiol, 2nd-fluoride only control, 3rd-fluoride/magnolol,4th-triclosan/fluoride control
6
Magnolol, Total/Whitening, Honokiol, Fluoride Control
1st-fluoride/Magnolol, 2nd-Fluoride/triclosan control, 3rd-fluoride/Honokiol,4th-fluoride only control
7
Total25

Baseline characteristics

CharacteristicTotal/Whitening, Honokiol, Fluoride Control, MagnololHonokiol, Fluoride Control, Magnolol, Total/WhiteningFluoride Control, Magnolol,Total/Whitening,HonokiolMagnolol, Total/Whitening, Honokiol, Fluoride ControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
6 Participants6 Participants6 Participants7 Participants25 Participants
Age Continuous37.8 years
STANDARD_DEVIATION 11.6
46.4 years
STANDARD_DEVIATION 10.9
42 years
STANDARD_DEVIATION 11.8
44.3 years
STANDARD_DEVIATION 7
42.1 years
STANDARD_DEVIATION 10.5
Region of Enrollment
United States
6 participants6 participants6 participants7 participants25 participants
Sex: Female, Male
Female
3 Participants3 Participants2 Participants7 Participants15 Participants
Sex: Female, Male
Male
3 Participants3 Participants4 Participants0 Participants10 Participants

Outcome results

Primary

Plaque Index

Plaque score scale: Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Fluoride OnlyPlaque Index2.45 Units on a scaleStandard Deviation 0.47
Total/WhiteningPlaque Index2.22 Units on a scaleStandard Deviation 0.46
Herbal Extract ToothpastePlaque Index2.54 Units on a scaleStandard Deviation 0.44
Herbal Extract ToothpastePlaque Index2.56 Units on a scaleStandard Deviation 0.46
Comparison: The null hypothesis states that there is no difference between groups.p-value: 0.05ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026